About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 196 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 196 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 196 trials

CompletedMedication Adherence in Schizophrenia: Development of a CBT-Based InterventionThis is a randomized pilot study of an intervention based on principles of Cognitive Behavioral Therapy (CBT).NCT00980252·Chicago, Illinois CompletedAn Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic MedicationAn Extension study to a clinical study that will continue to evaluate the effectiveness and safety of SEP-363856 in people with schizophrenia that switch to SEP-363856 from their…NCT05741528·Anaheim, California and 15 others CompletedCAFE Comparison of Atypicals in First Episode of PsychosisThe purpose of this study is to compare the effectiveness, tolerability, and efficacy of the currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day)…NCT00034892·Stanford, California and 25 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)The purpose of this study was to evaluate the efficacy and safety of elpipodect at a range of doses (8 mg, 16 mg, and 24 mg once daily \[QD\]) in adult participants who have an…NCT04624243·Bentonville, Arkansas and 120 others

CompletedStudy to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderThis is a randomized, single-dose, open-label, parallel-group study.NCT05321602·Little Rock, Arkansas and 8 others

CompletedStudy to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of SchizophreniaMIN-101C07 is a multicenter, multinational, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of roluperidone in adult…NCT03397134·Rogers, Arkansas and 38 others

CompletedDepakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of SchizophreniaThe purpose of this study is to assess the 14-day and 12-week safety and efficacy of Depakote ER used in combination with either olanzapine or risperidone versus antipsychotic…NCT00073164·Birmingham, Alabama and 34 others

Not yet recruitingHigher-Dose Maintenance With ERZOFRI 351 mg in Adults With SchizophreniaThis is a prospective, multicenter, open-label, single-arm study evaluating ERZOFRI (paliperidone palmitate) 351 mg administered every 4 weeks as maintenance treatment in…NCT07927946·Orange, California and 2 others

CompletedThinking Skills for Work in Severe Mental IllnessThe purpose of this study is help people with serious mental illness and receiving vocational rehabilitation get and keep the job they want by improving their thinking skills…NCT01926613·Chicago, Illinois and 1 other

RecruitingA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and AdolescentsThe purpose of this study is to evaluate the long-term safety and tolerability of Xanomeline and Trospium Chloride for the treatment of psychiatric disorders in children and…NCT07424404·Dothan, Alabama and 104 others

CompletedComparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase SchizophrenicsThe goal of this project is to show that the best possible option for preventing relapses in patients suffering from first episode (\<1 year of anti-psychotic medication) or early…NCT02360319·Tucson, Arizona and 38 others

RecruitingA Study to Evaluate the Effect of KarXT on Urological SafetyThe purpose of this study is to characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia.NCT07221877·Little Rock, Arkansas and 15 others

CompletedClinical Trial of BI 425809 Effect on Cognition and Functional Capacity in SchizophreniaThe objective of the study is to investigate the efficacy, safety and pharmacokinetics of four different doses of BI 425809 once daily compared to placebo given for 12 weeks in…NCT02832037·Garden Grove, California and 80 others

CompletedEffect of Lu AF35700 in Patients With Treatment-resistant SchizophreniaTo evaluate the efficacy of 10 and 20 mg/day of Lu AF35700 on schizophrenia symptoms in patients with treatment-resistant schizophrenia (TRS)NCT02717195·Bellflower, California and 146 others

CompletedA Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic PatientsThe primary objective of this study was to assess time to discontinuation due to lack of tolerability among patients with schizophrenia receiving LY2140023, given orally twice…NCT00845026·Escondido, California and 22 others

CompletedEffects of Risperdal Consta on Ability to Benefit From Social Skills Training in SchizophreniaThe specific aim of this study is to determine whether the new, long-acting, form of risperidone, Risperdal Consta, improves the ability of schizophrenia patients to benefit from…NCT00148083·Chicago, Illinois and 1 other

Active not recruitingA Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With SchizophreniaEvaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophreniaNCT06894212·Bentonville, Arkansas and 72 others

TerminatedStudy Evaluating Bifeprunox in Patients With Schizophrenia.An open-label extension study using a variable dose (20 to 30 mg daily) of bifeprunox to evaluate long-term safety.NCT00366327·Little Rock, Arkansas and 81 others

CompletedA Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.The purpose of this study is to evaluate the efficacy of paliperidone palmitate compared with placebo in the prevention of recurrence of the symptoms of schizophrenia and to…NCT00111189·Little Rock, Arkansas and 54 others

TerminatedA Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®To compare inpatient psychiatric hospitalization rates while participants are on oral standard-of-care antipsychotic treatment and later switched to Abilify MyCite®.NCT03892889·Phoenix, Arizona and 67 others

PreviousPage 5 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia